Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 215

1.

Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers.

Wu XC, Lund MJ, Kimmick GG, Richardson LC, Sabatino SA, Chen VW, Fleming ST, Morris CR, Huang B, Trentham-Dietz A, Lipscomb J.

J Clin Oncol. 2012 Jan 10;30(2):142-50. doi: 10.1200/JCO.2011.36.8399. Epub 2011 Dec 5.

PMID:
22147735
2.

The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care.

Freedman RA, Virgo KS, He Y, Pavluck AL, Winer EP, Ward EM, Keating NL.

Cancer. 2011 Jan 1;117(1):180-9. doi: 10.1002/cncr.25542. Epub 2010 Oct 11.

3.

Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005).

Chen AY, Halpern MT, Schrag NM, Stewart A, Leitch M, Ward E.

J Natl Cancer Inst. 2008 Apr 2;100(7):462-74. doi: 10.1093/jnci/djn057. Epub 2008 Mar 25.

PMID:
18364506
4.

Social and racial differences in selection of breast cancer adjuvant chemotherapy regimens.

Griggs JJ, Culakova E, Sorbero ME, Poniewierski MS, Wolff DA, Crawford J, Dale DC, Lyman GH.

J Clin Oncol. 2007 Jun 20;25(18):2522-7.

PMID:
17577029
5.

Effect of patient socioeconomic status and body mass index on the quality of breast cancer adjuvant chemotherapy.

Griggs JJ, Culakova E, Sorbero ME, van Ryn M, Poniewierski MS, Wolff DA, Crawford J, Dale DC, Lyman GH.

J Clin Oncol. 2007 Jan 20;25(3):277-84. Epub 2006 Dec 11.

PMID:
17159190
6.

The roles of teaching hospitals, insurance status, and race/ethnicity in receipt of adjuvant therapy for regional-stage breast cancer in Florida.

Richardson LC, Tian L, Voti L, Hartzema AG, Reis I, Fleming LE, Mackinnon J.

Am J Public Health. 2006 Jan;96(1):160-6. Epub 2005 Nov 29.

7.
8.

Disparities in breast cancer prognostic factors by race, insurance status, and education.

DeSantis C, Jemal A, Ward E.

Cancer Causes Control. 2010 Sep;21(9):1445-50. doi: 10.1007/s10552-010-9572-z. Epub 2010 May 27.

PMID:
20506039
9.

Health care system and socioeconomic factors associated with variance in use of sentinel lymph node biopsy for melanoma in the United States.

Bilimoria KY, Balch CM, Wayne JD, Chang DC, Palis BE, Dy SM, Lange JR.

J Clin Oncol. 2009 Apr 10;27(11):1857-63. doi: 10.1200/JCO.2008.18.7567. Epub 2009 Mar 9.

PMID:
19273706
10.

Treatment patterns for stage III colon cancer and factors related to receipt of postoperative chemotherapy in Louisiana.

Wu X, Chen VW, Andrews PA, Chen L, Hsieh M, Fontham ET.

J La State Med Soc. 2004 Sep-Oct;156(5):255-61.

PMID:
15554095
11.

The effect of race/ethnicity and insurance in the administration of standard therapy for local breast cancer in Florida.

Voti L, Richardson LC, Reis I, Fleming LE, Mackinnon J, Coebergh JW.

Breast Cancer Res Treat. 2006 Jan;95(1):89-95. Epub 2005 Oct 22.

PMID:
16244785
12.

Insurance status and the use of guideline therapy in the treatment of selected cancers.

Harlan LC, Greene AL, Clegg LX, Mooney M, Stevens JL, Brown ML.

J Clin Oncol. 2005 Dec 20;23(36):9079-88. Epub 2005 Nov 21.

PMID:
16301598
13.

Impact of race, socioeconomic status, and the health care system on the treatment of advanced-stage ovarian cancer in California.

Long B, Chang J, Ziogas A, Tewari KS, Anton-Culver H, Bristow RE.

Am J Obstet Gynecol. 2015 Apr;212(4):468.e1-9. doi: 10.1016/j.ajog.2014.10.1104. Epub 2014 Oct 31.

PMID:
25448522
14.

Delays in adjuvant chemotherapy treatment among patients with breast cancer are more likely in African American and Hispanic populations: a national cohort study 2004-2006.

Fedewa SA, Ward EM, Stewart AK, Edge SB.

J Clin Oncol. 2010 Sep 20;28(27):4135-41. doi: 10.1200/JCO.2009.27.2427. Epub 2010 Aug 9.

PMID:
20697082
15.

Breast cancer treatment guidelines in older women.

Giordano SH, Hortobagyi GN, Kau SW, Theriault RL, Bondy ML.

J Clin Oncol. 2005 Feb 1;23(4):783-91.

PMID:
15681522
17.

The impact of socioeconomic status and race on trial participation for older women with breast cancer.

Gross CP, Filardo G, Mayne ST, Krumholz HM.

Cancer. 2005 Feb 1;103(3):483-91.

18.

Substantial increase in the use of adjuvant systemic treatment for early stage breast cancer reflects changes in guidelines in the period 1990-2006 in the southeastern Netherlands.

Sukel MP, van de Poll-Franse LV, Nieuwenhuijzen GA, Vreugdenhil G, Herings RM, Coebergh JW, Voogd AC.

Eur J Cancer. 2008 Sep;44(13):1846-54. doi: 10.1016/j.ejca.2008.06.001. Epub 2008 Jul 17.

PMID:
18640030
19.
20.

Clinical and Demographic Factors Associated With Receipt of Non Guideline-concordant Initial Therapy for Nonmetastatic Prostate Cancer.

Hamilton AS, Fleming ST, Wang D, Goodman M, Wu XC, Owen JB, Lo M, Ho A, Anderson RT, Thompson T.

Am J Clin Oncol. 2016 Feb;39(1):55-63. doi: 10.1097/COC.0000000000000017.

Supplemental Content

Support Center